Diagnosis of disease at an early, curable, and reversible stage allows more conservative treatment and better patient outcomes. Fluorescence biosensing is a widely used method to detect biomarkers, which are early indicators of disease. Importantly, biosensing requires a high level of sensitivity. Traditionally, these sensors use antibodies or enzymes as biorecognition molecules; however, these can lack the specificity required in a clinical setting, limiting their overall applicability. Aptamers are short, single stranded nucleotides that are receiving increasing attention over traditional recognition molecules. These exhibit many advantages, such as high specificity, making them promising for ultrasensitive biosensors. Metal enhanced fluorescence (MEF) utilizes plasmonic materials, which can increase the sensitivity of label-based fluorescent biosensors. The fluorescence enhancement achieved by placing metallic nanostructures in close proximity to fluorophores allows for detection of ultra-low biomarker concentrations. Plasmonic biosensors have been successfully implemented as diagnostic tools for a number of diseases, such as cancer, yet reproducible systems exhibiting high specificity and the ability to multiplex remain challenging. Similarly, while aptasensors have been extensively reported, few systems currently incorporate MEF, which could drastically improve biosensor sensitivity. Here, we review the latest advancements in the field of aptamer biosensing based on MEF that have been explored for the detection of a wide variety of biological molecules. While this emerging biosensing technology is still in its infant stage, we highlight the potential challenges and its clinical potential in early diagnosis of diseases.
Skip Nav Destination
Aptamer biosensing based on metal enhanced fluorescence platform: A promising diagnostic tool
Article navigation
December 2021
Review Article|
October 26 2021
Aptamer biosensing based on metal enhanced fluorescence platform: A promising diagnostic tool
Savita M. Sundaresan;
Savita M. Sundaresan
Department of Materials and London Centre for Nanotechnology, Imperial College London
, London SW7 2AZ, United Kingdom
Search for other works by this author on:
S. M. Fothergill
;
S. M. Fothergill
Department of Materials and London Centre for Nanotechnology, Imperial College London
, London SW7 2AZ, United Kingdom
Search for other works by this author on:
Tanveer A. Tabish
;
Tanveer A. Tabish
Department of Materials and London Centre for Nanotechnology, Imperial College London
, London SW7 2AZ, United Kingdom
Search for other works by this author on:
Mary Ryan;
Mary Ryan
Department of Materials and London Centre for Nanotechnology, Imperial College London
, London SW7 2AZ, United Kingdom
Search for other works by this author on:
Fang Xie
Fang Xie
a)
Department of Materials and London Centre for Nanotechnology, Imperial College London
, London SW7 2AZ, United Kingdom
a)Author to whom correspondence should be addressed: f.xie@imperial.ac.uk
Search for other works by this author on:
a)Author to whom correspondence should be addressed: f.xie@imperial.ac.uk
Appl. Phys. Rev. 8, 041311 (2021)
Article history
Received:
August 05 2021
Accepted:
October 04 2021
Citation
Savita M. Sundaresan, S. M. Fothergill, Tanveer A. Tabish, Mary Ryan, Fang Xie; Aptamer biosensing based on metal enhanced fluorescence platform: A promising diagnostic tool. Appl. Phys. Rev. 1 December 2021; 8 (4): 041311. https://doi.org/10.1063/5.0065833
Download citation file:
Sign in
Don't already have an account? Register
Sign In
You could not be signed in. Please check your credentials and make sure you have an active account and try again.
Sign in via your Institution
Sign in via your InstitutionPay-Per-View Access
$40.00